News
The Swiss company’s over-the-counter wrist wearable, which uses optical sensors to gather blood pressure readings, will be available to U.S. consumers in 2026.
The company's platform aims to help commercial and medical affairs teams automate manual and rote tasks.
Astrana Health completes a $708 million acquisition that it announced in 2024.
The wristband is designed to alleviate essential tremors by modulating the nervous system and restoring motor control.
MAI-DxO AI reportedly diagnosed complex medical cases with over four times higher accuracy than generalist physicians and saved costs.
The spin-off company is expected to rake in almost $2 billion in revenue this year.
The acquisition is expected to boost Teleflex's global footprint in the peripheral intervention market.
The AI-based early warning system the NHS is developing is part of the government's 10 Year Health Plan to use data to identify patient safety concerns.
The acquisition, part of a strategic partnership to accelerate Arcadia's growth and innovation, marks an exit for former investor Peloton Equity.